Cancer clinical trials in the region Pays de la Loire
365 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 3
Head and neck cancer
#NCT04747054
Oral cavity
Oropharynx
Hypopharynx
Larynx
Other
Squamous cell carcinoma
Metastatic
None
Systemic Treatment-Naive
CPS Positive (1 <= X < 20)
CPS Positive (X >= 20)
20 recruiting sites
UNICANCER
Phase 3
Head and neck cancer
#NCT06706401
Oropharynx
Hypopharynx
Larynx
Squamous cell carcinoma
Localized
None
Systemic Treatment-Naive
Surgery
Immunotherapy
Targeted therapy
Radiotherapy
Radiochemotherapy
7 recruiting sites
Centre Léon Bérard
Phase 3
Head and neck cancer
#NCT06496178
#2023-510322-32-00
Oral cavity
Oropharynx
Hypopharynx
Larynx
Squamous cell carcinoma
Locally Advanced
Metastatic
1
Immunotherapy
Chemotherapy
15 recruiting sites
Merus
Phase 3
Head and neck cancer
#NCT05078047
Locally Advanced
Metastatic
Immunotherapy
29 recruiting sites
UNICANCER
Phase 3
Lung cancer
#NCT06119581
#2023-503412-33-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
BRAF
EGFR
HER2
MET
NTRK-1/2/3
RET
ROS-1
Immunotherapy
Chemotherapy
Targeted therapy
18 recruiting sites
Eli Lilly et compagnie
Phase 3
Lung cancer
#NCT06881784
#2024-518154-16-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
Other KRAS
HRAS
KRAS G12C
KRAS non G12C
KRAS G12D
NRAS
1
2
Immunotherapy
Chemotherapy
Systemic Treatment-Naive
16 recruiting sites
Revolution Medicines, Inc.
Phase 3
Stomach and esophageal cancer
#NCT06901531
#2024-519773-19-00
Stomach
Oesogastric junction
Adenocarcinoma
Locally Advanced
Metastatic
Claudin 18.2
None
Systemic Treatment-Naive
CPS Positive (1 <= X < 5)
CPS Positive (5 <= X < 10)
CPS Positive (X >= 10)
HER2
Immunotherapy
Chemotherapy
18 recruiting sites
Astellas Pharma Développement mondial, Inc.
Phase 3
Lymphoma
#NCT06091254
B cell lymphoma
Follicular lymphoma
None
Systemic Treatment-Naive
12 recruiting sites
Regeneron Pharmaceuticals
Phase 3
Lung cancer
#NCT06623422
#2023-506327-29-00
NSCLC (Non-Small Cell Lung Cancer)
Localized
Locally Advanced
None
Systemic Treatment-Naive
Systemic Treatment-Naive
ALK
EGFR
Immunotherapy
Immunotherapy
7 recruiting sites
Merck Sharp & Dohme LLC
Phase 3
Colon cancer
Rectal cancer
#NCT06252649
#2022-502352-31-00
Adenocarcinoma
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
Targeted therapy
Targeted therapy
16 recruiting sites
Amgen